Common mucus-thinning drugs may improve outcomes in COPD patients with lung cancer
Knowledge-focused
Ongoing
This study looks at whether taking muco-active agents (mucus-thinning drugs like N-acetylcysteine and ambroxol) after a lung cancer diagnosis is linked to better outcomes in people who also have COPD. Researchers will analyze data from a large Korean database, comparing those who…
Sponsor: Seoul National University • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC